Biostar Pharmaceuticals, Inc. (BSPM)
NGM · Common · CUSIP 090678301
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for BSPM and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
090678301 (prev. 090678202 )
Market Cap
Micro Cap · $5 Million
Business: Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures, and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company’s most popular product is its XinAoxingOleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population.
Notes: February 5, 2016 -- Biostar Pharmaceuticals, Inc. (BSPM) will effect a one-for-seven (1-7) reverse split of its common stock. In conjunction with the reverse split, the CUSIP number will change to 090678301.

Company Contact

CEO
Ronghua Wang
CFO
Qinghua Liu (Interim)
Investor Relations
office@aoxing-group.com
SEC EDGAR Filings
View filings »